IMPACT FACTOR
2023
1.5
|
MNiSW
20
|
Indexed in:
ESCI
Web of Science
Clarivate Analytics
|
JCI
0.31
Journal Citation Indicator
|
CiteScore 2023
2.8
Predicted CiteScore 2024
3.0
|
NEW Guidelines for Authors!
Clinical and Experimental Hepatology, is the official journal of the Polish Association for Study of Liver.
Indexed in PubMed and Web of Science Core Collection
3/2020
vol. 6
|
|
Review paper
Recommendations of the Polish Group of Experts
for HCV for the treatment of hepatitis C in 2020
Waldemar Halota,
Robert Flisiak,
Jacek Juszczyk,
Piotr Małkowski,
Małgorzata Pawłowska,
Krzysztof Simon,
Krzysztof Tomasiewicz
Clin Exp HEPATOL 2020; 6, 3: 163–169
Online publish date: 2020-09-01
DOI
:
https://doi.org/10.5114/ceh.2020.98606
Review paper
Interventional radiological management of hepatobiliary disorders in pregnancy
Pratyaksha Rana,
Pankaj Gupta,
Sreedhara B Chaluvashetty,
Ashima Mittal,
Naveen Kalra,
Usha Dutta,
Manavjit Singh Sandhu
Clin Exp HEPATOL 2020; 6, 3: 176–184
Online publish date: 2020-09-30
DOI
:
https://doi.org/10.5114/ceh.2020.99508
Review paper
Intrahepatic splenosis: a world review
Weh Shien Toh,
Kai Siang Chan,
Cristine Szu Lyn Ding,
Cher Heng Tan,
Vishal G. Shelat
Clin Exp HEPATOL 2020; 6, 3: 185–198
Online publish date: 2020-09-30
DOI
:
https://doi.org/10.5114/ceh.2020.99509
Original paper
The superior role of coagulation factor FX over FVII in adenoviral-mediated innate immune induction of the hepatocyte: an in vitro experiment
Saeed Firoozi Ghahestani,
Alireza Shiri,
Afagh Moattari,
Jamal Sarvari,
Ali Moahammad Tamaddon,
Seyed Younes Hosseini
Clin Exp HEPATOL 2020; 6, 3: 199–206
Online publish date: 2020-09-30
DOI
:
https://doi.org/10.5114/ceh.2020.99512
Original paper
Taurine mitigates cirrhosis-associated heart injury through mitochondrial-dependent and antioxidative mechanisms
Khadijeh Mousavi,
Hossein Niknahad,
Amin Ghalamfarsa,
Hamidreza Mohammadi,
Negar Azarpira,
Mohammad Mehdi Ommati,
Reza Heidari
Clin Exp HEPATOL 2020; 6, 3: 207–219
Online publish date: 2020-09-30
DOI
:
https://doi.org/10.5114/ceh.2020.99513
Original paper
Estimation of the risk of fibrosis in children with nonalcoholic fatty liver disease
Paweł Małecki,
Magdalena Figlerowicz,
Pawel Kemnitz,
Katarzyna Mazur,
Wojciech Służewski,
Anna Mania
Clin Exp HEPATOL 2020; 6, 3: 220–227
Online publish date: 2020-09-30
DOI
:
https://doi.org/10.5114/ceh.2020.99515
Original paper
Pediatric chronic liver failure-sequential organ failure assessment score and outcome of acute liver failure in children
Bassam Abdel Hakam Ayoub,
Mohammed Abdel Hafez Ali,
Tahany Abdel Hamid Salem,
Marwa Sabry Rizk,
Salma Abdel Megeed Nagi,
Nermin Mohammed Adawy
Clin Exp HEPATOL 2020; 6, 3: 228–234
Online publish date: 2020-09-18
DOI
:
https://doi.org/10.5114/ceh.2020.99129
Original paper
Serum concentrations of selected adipokines in virus-related
liver cirrhosis and hepatocellular carcinoma
Monika Pazgan-Simon,
Jolanta Zuwala-Jagiello,
Michał Kukla,
Ewa Grzebyk,
Krzysztof Simon
Clin Exp HEPATOL 2020; 6, 3: 235–242
Online publish date: 2020-09-30
DOI
:
https://doi.org/10.5114/ceh.2020.99517
Original paper
Can adequate analgesia be achieved in patients with cirrhosis without precipitating hepatic encephalopathy? A prospective study
Ashley Bloom,
Vanessa Weerasinghe Mudiyansalage,
Anna Rhodes,
Malcolm Hogg,
Chatura Jayasekera,
Alexandra Gorelik,
Siddharth Sood,
Amanda Nicoll
Clin Exp HEPATOL 2020; 6, 3: 243–252
Online publish date: 2020-09-30
DOI
:
https://doi.org/10.5114/ceh.2020.99521
Original paper
A new model to predict response to direct-acting antiviral therapy in decompensated cirrhotics due to hepatitis C virus
Prasanta Debnath,
Sanjay Chandnani,
Pravin Rathi,
Sujit Nair,
Parmeshwar Junare,
Suhas Udgirkar,
Anupam Singh,
Qais Contractor
Clin Exp HEPATOL 2020; 6, 3: 253–262
Online publish date: 2020-09-30
DOI
:
https://doi.org/10.5114/ceh.2020.99525
Original paper
MicroRNA-499 rs3746444 polymorphism in Egyptian children with biliary atresia
Eman Gawish,
Elhamy Abd El-Monem,
Mona El-Abd,
Gihan Ahmed Sobhy,
Heba Ghanem
Clin Exp HEPATOL 2020; 6, 3: 263–269
Online publish date: 2020-09-30
DOI
:
https://doi.org/10.5114/ceh.2020.99526
Original paper
Pemafibrate decreases markers of hepatic inflammation in patients with non-alcoholic fatty liver disease
Satoshi Shinozaki,
Toshiyuki Tahara,
Alan Kawarai Lefor,
Masahito Ogura
Clin Exp HEPATOL 2020; 6, 3: 270–274
Online publish date: 2020-09-30
DOI
:
https://doi.org/10.5114/ceh.2020.99528
|
